Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Monday, December 5, 2022 · 604,877,108 Articles · 3+ Million Readers

Continuous Glucose Monitoring System Market Global Survey, Analysis, Share, Company Profiles and Forecast by 2028

Emergen Research Logo

Emergen Research Logo

Rising prevalence of diabetes and increasing demand for continuous glucose monitoring systems for better diabetes management market revenue growth

Market Size – USD 4.31 Billion in 2020, Market Growth – at a CAGR of 19.6%, Market Trends ”
— Emergen Research

VANCOUVER, BRITISH COLUMBIA, CANADA, September 22, 2022 / -- The Global Companion Diagnostics Market report assesses the historical and current data along with a thorough analysis of the market dynamics. The report also sheds light on the significant market growth driving and restraining factors that are anticipated to influence the market growth through the forecast period. The report focuses on potential growth opportunities and limitations the prominent players of the industry might face during the entirety of the forecast timeline.
Companion diagnostics are techniques or tests that incorporate the knowledge required for the safe and effective use of a particular medical medicine. It enables the identification of the potential for a person to gain from or experience negative effects from a pharmaceutical drug. It helps determine how a procedure affects a patient so that medicines can be changed to enhance effectiveness and wellness. The growing focus on personalised medicine should open the door for companion diagnostics since it is a crucial component of it. Biomarkers and companion diagnostics are in high demand as a result of the increased detection and monitoring of numerous disorders. By driving up and growing R&D expenses and driving up drug approval rates, these diagnostic evaluations lengthen the product development cycle.
Get a sample of the report @
Utilizing the concept for collaboratively developing pharmaceutical diagnostics to assess how individuals respond to treatment options would boost market demand. In order to evaluate a drug's efficacy and any potential side effects, companion diagnostics are created alongside it. Alternative screening methods also allow for monitoring opioid reactions during the entire course of treatment. Better tests are obtained as a result of their frequent connections to the molecular, proteomic, and metabolomic characteristics of organisms. The advantages of co-development in the area of drug diagnostics that were previously discussed would increase consumer demand for companion diagnostics.
The report further studies the key companies operating in the industry and their company profiles, product portfolio, expansion strategies, and strategic alliances such as mergers and acquisitions, collaborations, and joint ventures, among others. It also offers insights into their market reach and global position, along with highlights about their achievements and financial standings.
Key companies operating in the Companion Diagnostics market include:
Agilent Technologies, Foundation Medicine, Myriad Genetic Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Arup Laboratories, Abbott, MolecularMD, BioMérieux, and Illumina, among others.
For the purpose of this report, Emergen Research has segmented into the global Companion Diagnostics Market based on the technology, disease indication, application, and region:
Technology Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
• Immunohistochemistry
• In Situ Hybridization
• Polymerase Chain Reaction
• Genetic Sequencing
Disease Indication Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Skin Cancer
Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
• Hospitals
• Diagnostic Laboratories
To know more about the report, visit @
Regional Analysis:
The report further examines the market in the key regions of the world with regard to production and consumption patterns, import/export, supply and demand ratio, revenue generation, market share and size, and presence of prominent players in the regions. The report also covers the expansion plans undertaken by companies in the regions under the regional analysis section.
Key regions in the market include:
• North America
o U.S.
o Canada
• Europe
o U.K.
o Italy
o Germany
o France
o Rest of EU
• Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of APAC
• Latin America
o Chile
o Brazil
o Argentina
o Rest of Latin America
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA
Key Questions Addressed in the Report:
• Who are the leading players in the Companion Diagnostics industry?
• Which region is expected to dominate the market in the coming years?
• What are the key applications of Companion Diagnostics?
• Which segment is expected to garner traction during the coming years?
• What are the key strategies adopted by leading players in the market?
Request customization of the report @
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release